Several studies have reported that miRNAs, small‐molecule inhibitors, antisense oligonucleotides, and peptide‐based immunotherapy can significantly downregulate BIRC5 expression, consequently inhibiting tumor cell growth.18 This evidence concerns the gene BIRC5 and neoplasm.